[Amphotericin B-intralipid 20% combination. In vivo evaluation of its tolerability].
Débat Zoguéreh
D
D
Poignard
P
P
Sorriaux
A
A
Brouqui
P
P
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D004337:Drug Carriers; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008055:Lipids; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
D000935:Antifungal Agents; D004337:Drug Carriers; D005217:Fat Emulsions, Intravenous; D008055:Lipids; D000666:Amphotericin B